MedPath

Evaluation of Torvaptan on postoperative edema after cardiac surgery.

Not Applicable
Conditions
ischemic heart disease, heart valvular disease, diseases of thoracic aorta
Registration Number
JPRN-UMIN000012392
Lead Sponsor
Department of Thoracic and Cardiovascular Surgery, Hirosaki University Graduate School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

(1)Patients who had had allergic response to Truvaptan or analogous compound(eg.mozavaptan) (2) Anuric patients (3)Patients who do not feel thirst or oral fluid intake difficulty (4)Hypernatremia(Na>147mEq/L) (5)Women who are pregnant, breast-feeding or having will of pregnancy (6)Oral feeding difficulty after surgery (7)Malignacy (8)Severe hepatic damage or renal dysfunction (9)Others judged as innapropriate candidate by the researcher(s)

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath